首页> 外国专利> A USE OF THE LIQUIRITIGENIN ABUNDANT EXTRACT OR LIQUIRITIGENIN DERIVED THEREFROM FOR INCREASING BILE FLOW, CHOLERETIC EFFECT, AND FOR PREVENTING AND TREATING CHOLESTATIC LIVER DISEASES

A USE OF THE LIQUIRITIGENIN ABUNDANT EXTRACT OR LIQUIRITIGENIN DERIVED THEREFROM FOR INCREASING BILE FLOW, CHOLERETIC EFFECT, AND FOR PREVENTING AND TREATING CHOLESTATIC LIVER DISEASES

机译:脂联蛋白原丰富提取物或脂联蛋白原衍生的用途用于增加胆汁流量,胆汁淤积作用以及预防和治疗胆汁淤积性肝病

摘要

The present invention is related to a composition comprising an extract of licorice or liquiritigenin derived therefrom, which significantly increases bile flow rate and biliary excretion of bile acid, GSH and bilirubin. Consistent with these results, the inventive composition comprising an extract of licorice or liquiritigenin derived therefrom decrease the blood chemical markers including ALT as a hepatoprotective marker, and ALP and γ-GTP, as cholestatasis markers, and histochemical markers including central necrosis and inflammation in galactosamine/lipopolysaccharide-induced hepato-toxicity animal model when the inventive extract or compound of the present invention was orally and intravenously administrated thereto.
机译:本发明涉及一种组合物,该组合物包含由其衍生的甘草或脂蛋白原的提取物,其显着提高胆汁流速和胆汁酸,GSH和胆红素的胆汁排泄。与这些结果一致,本发明的组合物包含由其衍生的甘草或脂蛋白原的提取物降低了血液化学标志物,包括ALT作为保肝标志物,以及ALP和γ-GTP作为胆汁淤积标志物,以及组织化学标志物包括半乳糖胺中的中央坏死和炎症。当将本发明的提取物或本发明的化合物经口服和静脉内给药时,β-脂多糖诱导的肝毒性动物模型。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号